REMOPHAN 75 µg/ml solution for injection

Homepage Products Veterinary products REMOPHAN 75 µg/ml solution for injection

Pharmaceutical form

Solution for injection.

Clear, colourless solution.

Composition

Dexcloprostenolum                   75 µg (Dexcloprostenolum natricum)

Indication

Biotechnological

   - synchronization and induction of oestrus in cattle

   - synchronization of the reproductive cycle of the donors and recipients within an early embryo transfer programme for cattle

   - induction of delivery in sows

Therapeutic

Cattle: functional disturbances of the ovaries, postpartal and post-service anestrus (silent oestrus, irregular and anovulative cycle, persisting corpus luteum, luteal cyst). Postpuerperal uterus disease, endometritis, pyometra. Interruption of normal and pathological gestation (in the first half of the gestation period). Combined therapy of follicular cysts (on day 10 to 14 after administration of LHRH, after identifying a positive ovarian response).

Target animals

Cattle, pigs.

Dosage and application

Method of administration: intramuscularly.

Cattle: Synchronization of oestrus – 2 ml of the product pro toto (0.15 mg of the active substance). Following identification of corpus luteum (cycle days 6 to 18), insemination is performed 70 to 120 hours after administration, in dependence on the signs of onset of the oestrus. Application can be repeated on day 11 following the first application if no oestrus has been induced. Embryo donors receive the product on day 3 from the onset of superovulation preparation (2 ml pro toto in the morning, 2 ml pro toto in the evening). In the treatment of functional disorders of the ovaries, insemination is performed during the first oestrus induced by the administration of the product. The application can be repeated on day 11 if no oestrus has occurred. During a combined therapy of follicular cysts, REMOPHAN 75µg/ml solution for injection is applied on day 10 to 14 following administration of LH-RH (Lecirelin Bioveta 0.025mg/ml inj.) based on identification of a positive ovarian response. In the treatment of the postpuerperal uterus disease, administration is repeated in a 10-day interval. Insemination is only performed following the second application.

Sows: A single dose (behind the ear) of 1 ml of the product pro toto (75 μg of the active substance) is applied after gestation day 111. Induced birth will mostly start 19 to 30 hours after application.

Storage

Store below 25 ºC.

Protect from frost.

Store the injection vial in the carton to protect it from light.

Withdrawal period

Meat – 24 hours.

Milk – 4 hours.

Shelf life

Shelf life of the veterinary medicinal product in intact package: 2 years.

Shelf life after the first opening of the inner package: 14 days.

Package

10 x 2 ml, 20 x 2 ml, 1 x 10 ml, 5 x 10 ml.

Not all pack sizes may be marketed.